Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2022
Preoperative Chemoradiotherapy plus Nivolumab before Surgery in Patients with Microsatellite Stable and Microsatellite Instability-High Locally Advanced Rectal CancerHideaki Bando, Yuichiro Tsukada, Koji Inamori, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2024
Novel ERBB2 Variant Potentially Associated with Resistance against Anti-HER2 Monoclonal Antibody-Based Therapy in ERBB2-Amplified Metastatic Colorectal CancerNaoko Iida, Mitsuho Imai, Wataru Okamoto, et al.
British Journal of Cancer|October 4, 2017
Clinical significance of BRAF non-V600E mutations on the therapeutic effects of anti-EGFR monoclonal antibody treatment in patients with pretreated metastatic colorectal cancer: the Biomarker Research for anti-EGFR monoclonal Antibodies by Comprehensive Cancer genomics (BREAC) studyEiji Shinozaki, Takayuki Yoshino, Kentaro Yamazaki, et al.
Cancer Science|May 20, 2023
Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancersKanako Hagio, Junko Kikuchi, Kohichi Takada, et al.
International Journal of Clinical Oncology|March 1, 2023
Regulation of MEK inhibitor selumetinib sensitivity by AKT phosphorylation in the novel BRAF L525R mutantChikako Nakai, Sachiyo Mimaki, Koutatsu Matsushima, et al.
Frontiers in Oncology|November 28, 2022
Study protocol for HGCSG1801: A multicenter, prospective, phase II trial of second-line FOLFIRI plus aflibercept in patients with metastatic colorectal cancer refractory to anti-EGFR antibodiesHiroshi Nakatsumi, Yoshito Komatsu, Tetsuhito Muranaka, et al.
Cancer Science|October 19, 2020
FMS-like tyrosine kinase 3 (FLT3) amplification in patients with metastatic colorectal cancerHiroko Hasegawa, Hiroya Taniguchi, Yoshiaki Nakamura, et al.
JCO Precision Oncology|May 11, 2022
Effects of Metastatic Sites on Circulating Tumor DNA in Patients With Metastatic Colorectal CancerHideaki Bando, Yoshiaki Nakamura, Hiroya Taniguchi, et al.
Nature Medicine|November 12, 2021
Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trialYoshiaki Nakamura, Wataru Okamoto, Takeshi Kato, et al.
Frontiers in Oncology|July 2, 2021
Clinical Impact of Primary Tumor Location in Metastatic Colorectal Cancer Patients Under Later-Line Regorafenib or Trifluridine/Tipiracil TreatmentHiromichi Nakajima, Shota Fukuoka, Toshiki Masuishi, et al.
Pageof 12